- Home
- SILA vs CNTA Comparison
SILA vs CNTA Comparison
Compare SILA & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILA
- CNTA
- Stock Information
- Founded
- SILA 2013
- CNTA 2020
- Country
- SILA United States
- CNTA United Kingdom
- Employees
- SILA N/A
- CNTA N/A
- Industry
- SILA
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- SILA
- CNTA Health Care
- Exchange
- SILA NYSE
- CNTA Nasdaq
- Market Cap
- SILA 1.4B
- CNTA 1.6B
- IPO Year
- SILA N/A
- CNTA 2021
- Fundamental
- Price
- SILA $23.60
- CNTA $14.30
- Analyst Decision
- SILA Strong Buy
- CNTA Strong Buy
- Analyst Count
- SILA 2
- CNTA 10
- Target Price
- SILA $28.00
- CNTA $28.78
- AVG Volume (30 Days)
- SILA 848.5K
- CNTA 999.0K
- Earning Date
- SILA 08-05-2025
- CNTA 08-12-2025
- Dividend Yield
- SILA 6.80%
- CNTA N/A
- EPS Growth
- SILA 45.68
- CNTA N/A
- EPS
- SILA 0.63
- CNTA N/A
- Revenue
- SILA $184,473,000.00
- CNTA $15,000,000.00
- Revenue This Year
- SILA $7.93
- CNTA N/A
- Revenue Next Year
- SILA $9.13
- CNTA N/A
- P/E Ratio
- SILA $37.42
- CNTA N/A
- Revenue Growth
- SILA N/A
- CNTA 118.88
- 52 Week Low
- SILA $21.12
- CNTA $9.00
- 52 Week High
- SILA $27.50
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- SILA N/A
- CNTA 59.61
- Support Level
- SILA N/A
- CNTA $13.22
- Resistance Level
- SILA N/A
- CNTA $14.14
- Average True Range (ATR)
- SILA 0.00
- CNTA 0.68
- MACD
- SILA 0.00
- CNTA 0.10
- Stochastic Oscillator
- SILA 0.00
- CNTA 86.77
About SILA SILA REALTY TRUST INC
Sila Realty Trust Inc is a real estate investment trust. Its investment objective is to pay regular cash distributions to stockholders and to preserve, protect, and return capital contributions to stockholders. The company owns and manages healthcare assets. The company generates revenue from real estate investments in healthcare properties.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.